Conclusion The current evidence on the benefits of EOs as a functional ingredient in neutralizing MASLD is rather limited, future investigation with well- designed methodologies is utmost required to validate preclinical findings, optimize dosing regimens, determine long-term safety and efficacy in humans
Read more GLP-1 medications like Ozempic can lower blood sugar, especially when combined with other diabetes drugs
Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs
What is the advantage of Epithalon 50mg over the 10mg vial
Quality Each batch is verified by HPLC and LC-MS mass spectrometry
Keywords: Glucagon-like peptide-1 receptor agonists, Dipeptidyl peptidase-4 inhibitors, Type 2 diabetes mellitus, Cardiovascular outcome Background Type 2 diabetes mellitus (T2DM), a common metabolic disorder characterized by insulin resistance and inadequate insulin secretion by pancreatic cells, has become a growing cause of morbidity and mortality worldwide